15th International Symposium on Hyphenated Techniques in Chromatography and Separation Technology (HTC-15)
A preview of HTC-15, which will be held at Cardiff City Hall, Cardiff, United Kingdom, from 24–26 January 2018.
Photo Credit: Billy Stock/Shutterstock.com
A preview of HTC-15, which will be held at Cardiff City Hall, Cardiff, United Kingdom, from 24–26 January 2018.
The 15th International Symposium on Hyphenated Techniques in Chromatography and Separation Technology (HTC-15) will be held at Cardiff City Hall, Cardiff, United Kingdom, from 24–26 January 2018.
This is only the second time HTC has been held within the UK and the event is sure to be the premier analytical meeting in the UK for 2018, attracting national and internally renowned scientists. The meeting is organized by the Royal Society of Chemistry Separation Science Group with the Royal Flemish Chemical Society (KVCV). Full meeting details can be found at http://htc-conference.co.uk/.
The conference will include five plenary lectures, 16 keynote lectures, eight tutorial lectures, 48 oral presentations, and 24 early career researcher (ECR) presentations plus daily poster sessions. The programme will include topics such as Big Data, Fundamentals and Exploiting Separation Science, (R)evolutions in Biopharmaceutical Analysis, Food and Drink, Environmental, Comprehensive Chromatography, and many more. There will also be a dedicated ECR programme as one of the three parallel sessions. Sponsorship has been secured for ECRs and there is free registration for presenters in this session. Details can be found at https://www.ilmexhibitions.com/htc/bursary-guidelines/.
Conference registration (https://www.ilmexhibitions.com/htc/registration/) is now open. The aim is for 50–60% of presentations to be via abstract submission so please submit your abstracts now https://www.ilmexhibitions.com/htc/abstract-submission/.
Alongside the core scientific programme, the symposium will host an attractive technical exhibition where companies active in the field will present their latest developments in instrumentation, software, and applications related to the hyphenation of separation, detection, and sample preparation techniques topped with technical seminars. Thirteen companies have signed up already (https://www.ilmexhibitions.com/htc/floorplan/) and more are expected to follow shortly. If you are interested in exhibiting at HTC-15 please follow the link on the website to secure your place.
Cardiff is the closest capital city to London and Cardiff Airport is just a 20 min journey, easily accessible by car or shuttle. Bristol International Airport is also only 1 h away with fights from 112 different countries.
If travelling via London remember to book your onwards journey in advance. We can offer an exclusive deal with Great Western Railway (GWR). This offers reduced rates for delegates travelling at any time to Cardiff Central Station from all main GWR stations, including London Paddington, as well as many connecting routes to Great Western Railway from the home counties, see https://www.ilmexhibitions.com/htc/location-direction/.
The conference will be preceded by two short courses on the 23rd January 2018, one covering Practical SFC and the other Biopharmaceuticals.
On behalf of the Organizing Committees I look forward to welcoming you to HTCâ15 in the historic city of Cardiff and to City Hall. It is the centrepiece of one of the world’s finest civic centres, an area of impressive buildings, landscaped gardens, and tree-lined avenues.
Professor John Langley, Chair of HTC-15
E-mail:info@ilmexhibitions.comWebsite: www.ilmexhibitions.com/htc
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
